文献速递免疫规划传染病防控与疫情报告

以色列婴儿接种bOPV后口服及粪便脊髓灰质炎疫苗病毒排出情况

Oral and fecal polio vaccine excretion following bOPV vaccination among Israeli infants.
PubMed 文献 · Vaccine · 2023-06-01

该研究在以色列11个日托中心便利抽样6-32月龄婴幼儿,采集粪便和唾液样本,评估IPV基础免疫儿童接种bOPV后Sabin株排出情况。结果显示粪便排出在接种后持续7周,2、3、7周排出率分别为80%、50%、20%;接种3剂或4剂IPV儿童间排出率和持续时间无显著差异;男孩排出病毒的可能性是女孩的2.3倍(p=0.006);唾液排出在接种后4天和6天分别见于1/47(2%)和1/49(2%)样本。

要点

  • IPV基础免疫儿童接种bOPV后粪便Sabin株排出可持续7周。
  • 接种3剂或4剂IPV儿童间排出率和持续时间无显著差异。
  • 男孩排出病毒的可能性是女孩的2.3倍(p=0.006)。

核心结论

  • IPV基础免疫儿童接种bOPV后粪便Sabin株检出持续7周;额外剂次IPV未增强肠道免疫;唾液排出有限,持续至接种后一周。

研究设计与样本

  • 研究在以色列11个日托中心以便利抽样纳入6-32月龄婴幼儿,采集粪便和唾液样本,评估接种bOPV后Sabin株排出情况。

主要发现

  • 共采集251名儿童的398份粪便样本,其中168名儿童在采样前4-55天接种bOPV。
  • 接种后2、3、7周粪便排出率分别为80%、50%、20%。
  • 接种3剂或4剂IPV儿童间阳性样本率和持续时间无显著差异。
  • 男孩排出病毒的可能性是女孩的2.3倍(p=0.006)。
  • 接种后4天和6天唾液Sabin株排出分别见于1/47(2%)和1/49(2%)样本。

临床怎么用

  • 作者认为该数据可增进对不同免疫程序所获肠道免疫的理解,并指导bOPV接种后儿童接触防护建议。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Inactivated polio virus (IPV) vaccinations are a mainstay of immunization schedules in developed countries, while oral polio vaccine (OPV) is administered in developing countries and is the main vaccine in outbreaks. Due to circulating wild poliovirus (WPV1) detection in Israel (2013), oral bivalent polio vaccination (bOPV) was administered to IPV primed children and incorporated into the vaccination regimen. OBJECTIVES: We aimed to determine the extent and timeframe of fecal and salivary polio vaccine virus (Sabin strains) shedding following bOPV vaccination among IPV primed children. METHODS: Fecal samples were collected from a convenience sample of infants and toddlers attending 11 Israeli daycare centers. Salivary samples were collected from infants and toddlers following bOPV vaccination. RESULTS: 398 fecal samples were collected from 251 children (ages: 6-32 months), 168 received bOPV vaccination 4-55 days prior to sample collection. Fecal excretion continued among 80 %, 50 %, and 20 %, 2, 3, and 7 weeks following vaccination. There were no significant differences in the rate and duration of positive samples among children immunized with 3 or 4 IPV doses. Boys were 2.3-fold more likely to excrete the virus (p = 0.006). Salivary shedding of Sabin strains occurred in 1/47 (2 %) and 1/49 (2 %) samples 4, and 6 days following vaccination respectively. CONCLUSIONS: Fecal detection of Sabin strains among IPV-primed children continues for 7 weeks; additional doses of IPV do not augment intestinal immunity; limited salivary shedding occurs for up to a week. This data can enhance understanding of intestinal immunity achieved by different vaccination schedules and guide recommendations for contact precautions of children following bOPV vaccination.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Chorin O, Markovich MP, Avramovich E, et al. Oral and fecal polio vaccine excretion following bOPV vaccination among Israeli infants. Vaccine. 2023. PMID: 37268556. doi:10.1016/j.vaccine.2023.05.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。